Skip to main content
All lobbying filings

EAST END GROUP, LLC

Lobbying for FRESENIUS KABI · Development and production of essential medicines, biologics, and nutrition products.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $45,000.00 income · posted Jan 20, 2026

Official filing document

 Lobbying activity 3
Health Issues

Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.

Manufacturing

Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.

Tariff (miscellaneous tariff bills)

Section 232 investigation into pharmaceuticals and unfair trade practices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem